settlements, saying they cost consumers the equivalent of about $3.5 billion a year in higher prices for pharmaceuticals. The agency is pressing the courts and Congress to limit the settlements. Brand and generic drugmakers say the deals may bring...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to ���Pay for Delay��� Drug Deals Should Be Halted, FTC Tells Court
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account